Swarthmore Group Inc CIK has 13F portfolio worths $1.07 billion, as per its recent SEC 13F filing, and its top 10 holdings account for 46.87% of its net portfolio. Ms. Paula Mandle is the CEO of the Swarthmore Group, Inc and it was founded in 1991 James E. Nevels. AbbVie Inc (NYSE:ABBV), Gilead Sciences, Inc. (NASDAQ:GILD), Ecolab Inc. (NYSE:ECL) are among the top three stock holdings of the company.
AbbVie Inc (NYSE:ABBV) is the primary investment of Swarthmore Group Inc CIK with 762,150 shares with market value of $44 million. AbbVie Inc (NYSE:ABBV) reported second quarter 2014 revenues of $4.92 billion with GAAP EPS of 68 cents. D E Shaw is the primary investor of AbbVie Inc (NYSE:ABBV) with investments worth $365 million and 6,473,696 shares of the company. The second largest investor of the company is Orbimed Advisors with investments worth $293 million in the company followed by Arrowstreet Capital ($266 million).
Swarthmore Group Inc CIK has investments worth $41 million in Gilead Sciences, Inc. (NASDAQ:GILD) with 394,075 shares. Gilead Sciences, Inc. (NASDAQ:GILD) announced net revenue of $6.53 billion with net income of $3.66 billion for the second quarter 2014. Egerton Capital Limited is the primary investor of Gilead Sciences, Inc. (NASDAQ:GILD) with investments worth $509 million followed by Orbis Investment Management ($509 million) and Columbus Circle Investors ($398 million).
Ecolab Inc. (NYSE:ECL) is the third largest stock holding of Swarthmore Group Inc CIK with investments exceeding $41 million and 363,175 shares of the company. Ecolab Inc. (NYSE:ECL) reported net sales of $3.56 billion for the second quarter 2014 with net income of $311 million. Eagle Capital Management is the primary investor of Ecolab Inc. (NYSE:ECL) with investments worth $1.09 billion followed by Bill & Melinda Gates Foundation Trust ($486 million) and Cantillon Capital Management ($283 million).
This article has been written by Prakash Pandey and edited by Serkan Unal.
Related News: “Google-Funded Calico Resources Corp (CKB) and AbbVie Inc (ABBV) to Jointly Launch a $1.5 Billion Aging Research Center”
